Page 77 - Syndipharma

Iranian Parenteral and Pharmaceutical Company

IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

Founded: 1956

HQ office and plant location: Emmamzadeh Abolhasan St. Rajaei Highway, Tehran

Capital: 700,000,000,000 Rial

Major Shareholder: IPPC is a member of the Stock Market

Employees: 315 Persons

Company Profile:
Our mission is to save and protect the lives of the patients. Our commitment is to provide high-quality products and
services.
Our goal is to achieve the highest level of quality. We are striving to create a positive impact on the future genera-
tion. Creating value for patients, customers, employees, business partners, investors, shareholders, and the global
community.

Production line:
Our production lines are using the latest technology. We adopt production and control equipment ac-
cording to the world’s highest standards to ensure our commitment to maintain high quality and meet
the requirements of our customers in the best manner.
LVP:
Bottle Pack 360
Bottle Pack 321
Bottle Pack 321-200
SVP:
Bottle Pack 123
OPH
Solids

Certificates:
The company received approval and many awards from professional and legal authorities such as:
FCC Mark and International Standard, First Selection of Customers and Investors in Exchange Trades in Germany in
2014.
Golden mark of quality and product quality from the Bainex expert’s forum in 2014
Receiving the “Brand Reputation” Award from the European Union EBC * L and the Brand Clinic hosted by Croatian
in Zagreb
Achieving the second rank of quality and transparency of information among the participant companies, IPPC was
admitted to the exchange market with the growth of relevant indexes in the year 2013
ISO 9001:2008, Quality Austria

Capacity for Exports:
LVP : 15,000,000 bottles for Export and 33,000,000 Bottle for domestic market
SVP: 15,000,000 vials for Export and 22,000,000 vial for domestic market

Target Countries for Exports:
IRAQ, AFGHANISTAN, TAJIKISTAN, SYRIA

Premier Partners:
Rommelag, Swiss

76